Literature DB >> 20200252

A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection.

Keer Sun1, Luisa Torres, Dennis W Metzger.   

Abstract

Interleukin-10 (IL-10) is an important anti-inflammatory molecule that can cause immunosuppression and long-term pathogen persistence during chronic infection of mice with viruses such as lymphocytic choriomeningitis virus. However, its specific role in immunity to acute viral infections is not fully understood. We found that IL-10 plays a detrimental role in host responses to acute influenza A virus since IL-10(-/-) mice had improved viral clearance and survival after infection compared to wild-type mice. Enhanced viral clearance in IL-10(-/-) mice was not correlated with increased CD4(+) or CD8(+) T-cell recruitment into the lung but was correlated with increased pulmonary anti-influenza virus antibody titers, and this was dependent upon the presence of T cells, primarily CD4(+) T cells. In addition, virus-specific antibody produced during the early stages of infection in the respiratory tract of IL-10(-/-) but not wild-type mice was sufficient to mediate passive protection against viral challenge of naïve mice. Complement was necessary for this antibody-mediated passive protection, but FcgammaR or neutrophil deficiency did not significantly influence viral clearance. Our results show that an absence of IL-10 at the time of primary infection leads to enhanced local virus-specific antibody production and, thus, increased protection against influenza A virus infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200252      PMCID: PMC2863832          DOI: 10.1128/JVI.02408-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  The role of the antibody response in influenza virus infection.

Authors:  W Gerhard
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis.

Authors:  Emma H Wilson; Ulrike Wille-Reece; Florence Dzierszinski; Christopher A Hunter
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

3.  IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation.

Authors:  J F Marcelletti; D H Katz
Journal:  Cell Immunol       Date:  1996-01-10       Impact factor: 4.868

4.  High interleukin-10 production is associated with low antibody response to influenza vaccination in the elderly.

Authors:  Emanuela Corsini; Luigi Vismara; Laura Lucchi; Barbara Viviani; Stefano Govoni; Corrado L Galli; Marina Marinovich; Marco Racchi
Journal:  J Leukoc Biol       Date:  2006-05-17       Impact factor: 4.962

5.  Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection.

Authors:  Nicole Schmitz; Michael Kurrer; Martin F Bachmann; Manfred Kopf
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

Authors:  Kathryn B Renegar; Parker A Small; Lou G Boykins; Peter F Wright
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

Review 8.  Cell-mediated protection in influenza infection.

Authors:  Paul G Thomas; Rachael Keating; Diane J Hulse-Post; Peter C Doherty
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

9.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  61 in total

Review 1.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

2.  IL-10 Regulates Memory T Cell Development and the Balance between Th1 and Follicular Th Cell Responses during an Acute Viral Infection.

Authors:  Yuan Tian; Sarah B Mollo; Laurie E Harrington; Allan J Zajac
Journal:  J Immunol       Date:  2016-07-08       Impact factor: 5.422

3.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Authors:  Seagal Teitz-Tennenbaum; Steven P Viglianti; Jonathan A Roussey; Stuart M Levitz; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

4.  Surface receptor Toso controls B cell-mediated regulation of T cell immunity.

Authors:  Jinbo Yu; Vu Huy Hoang Duong; Katrin Westphal; Andreas Westphal; Abdulhadi Suwandi; Guntram A Grassl; Korbinian Brand; Andrew C Chan; Niko Föger; Kyeong-Hee Lee
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

5.  Differential mucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults.

Authors:  David Verhoeven; Sheldon Perry
Journal:  Immunol Cell Biol       Date:  2016-09-15       Impact factor: 5.126

6.  Cutting Edge: IL-10 Is Essential for the Generation of Germinal Center B Cell Responses and Anti-Plasmodium Humoral Immunity.

Authors:  Jenna J Guthmiller; Amy C Graham; Ryan A Zander; Rosemary L Pope; Noah S Butler
Journal:  J Immunol       Date:  2016-12-09       Impact factor: 5.422

7.  Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.

Authors:  Dennis W Metzger; Sharon L Salmon; Girish Kirimanjeswara
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

Review 8.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

9.  A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine.

Authors:  Géraldine Schlecht-Louf; Marianne Mangeney; Hanane El-Garch; Valérie Lacombe; Hervé Poulet; Thierry Heidmann
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

Review 10.  The effector T cell response to influenza infection.

Authors:  Matthew M Hufford; Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.